MedPath

WATSON LABORATORIES, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:1

Trial Phases

1 Phases

Phase 3:3

Drug Approvals

1

NMPA:1

Drug Approvals

Oxybutynin Transdermal Patch

Product Name
奥昔布宁透皮贴剂
Approval Number
H20140797
Approval Date
Oct 17, 2014
NMPA

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (100.0%)

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
First Posted Date
2013-02-11
Last Posted Date
2013-02-11
Lead Sponsor
Watson Laboratories, Inc.
Target Recruit Count
708
Registration Number
NCT01788384

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.